Stratified Prognostic Comparison Between Stage IIB-IVA Cervical Adenocarcinoma and Squamous Cell Carcinoma: A SEER Database-Based Study

References

• Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229–232. doi:10.1016/j.jnma.2020.03.002
   PubMed Web of Science ®Google Scholar
• Hodgson A, Park KJ. Cervical adenocarcinomas: a heterogeneous group of tumors with variable etiologies and clinical outcomes. Arch Pathol Lab Med. 2019;143(1):34–46. doi:10.5858/arpa.2018-0259-RA
   PubMed Web of Science ®Google Scholar
• Smith A, Beavis AL, Rositch AF, Levinson K. Disparities in diagnosis and treatment of cervical adenocarcinoma compared with squamous cell carcinoma: an analysis of the national cancer database, 2004–2017. J Low Genit Tract Dis. 2023;27(1):29–34. doi:10.1097/LGT.0000000000000702
   PubMed Web of Science ®Google Scholar
• Hohn AK, Brambs CE, Hiller G, May D, Schmoeckel E, Horn LC. 2020 WHO classification of female genital tumors. Geburtshilfe Frauenheilkd. 2021;81(10):1145–1153. doi:10.1055/a-1545-4279
   PubMed Web of Science ®Google Scholar
• Lee J, Kim YT, Kim S, et al. Prognosis of cervical cancer in the era of concurrent chemoradiation from national database in Korea: a comparison between squamous cell carcinoma and adenocarcinoma. PLoS One. 2015;10(12):e144887. doi:10.1371/journal.pone.0144887
   PubMed Web of Science ®Google Scholar
• Jung EJ, Byun JM, Kim YN, et al. Cervical adenocarcinoma has a poorer prognosis and a higher propensity for distant recurrence than squamous cell carcinoma. Int J Gynecol Cancer. 2017;27(6):1228–1236. doi:10.1097/IGC.0000000000001009
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu SG, Sun JY, et al. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis. J Cancer Res Clin Oncol. 2017;143(1):115–122. doi:10.1007/s00432-016-2246-9
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2000;79(2):289–293. doi:10.1006/gyno.2000.5935
   PubMed Web of Science ®Google Scholar
• Pausch TM, Liu X, Cui J, et al. Survival benefit of resection surgery for pancreatic ductal adenocarcinoma with liver metastases: a propensity score-matched SEER database analysis. Cancers. 2021;14(1):57. doi:10.3390/cancers14010057
   PubMed Web of Science ®Google Scholar
• Vesterinen E, Forss M, Nieminen U. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements. Gynecol Oncol. 1989;33(1):49–53. doi:10.1016/0090-8258(89)90602-1
   PubMed Web of Science ®Google Scholar
• Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24-Year Population-Based Study. Gynecol Oncol. 2000;78(2):97–105. doi:10.1006/gyno.2000.5826
   PubMed Web of Science ®Google Scholar
• Xu Y, Luo H, Hu Q, Zhu H. Identification of potential driver genes based on multi-genomic data in cervical cancer. Front Genet. 2021;12:598304. doi:10.3389/fgene.2021.598304
   PubMed Web of Science ®Google Scholar
• Li J, Xue X, Zhang Y, et al. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma – a multi-center study in Chinese patients with uterine cervical cancer. Gynecol Oncol. 2023;175:133–141. doi:10.1016/j.ygyno.2023.05.071
   PubMed Web of Science ®Google Scholar
• Qiu J, Qu X, Wang Y, et al. Single‐cell landscape highlights heterogenous microenvironment, novel immune reaction patterns, potential biomarkers and unique therapeutic strategies of cervical squamous carcinoma, Human Papillomavirus‐Associated (HPVA) and Non‐HPVA Adenocarcinoma. Adv Sci. 2023;10(10). doi:10.1002/advs.202204951
   Web of Science ®Google Scholar
• Sundfør K, Lyng H, Rofstad EK. Oxygen tension and vascular density in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Acta Oncol. 1998;37(7–8):665–670. doi:10.1080/028418698430016
   PubMed Web of Science ®Google Scholar
• Heeren AM, Punt S, Bleeker MC, et al. Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix. Mod Pathol. 2016;29(7):753–763. doi:10.1038/modpathol.2016.64
   PubMed Web of Science ®Google Scholar
• Tornesello ML, Buonaguro L, Buonaguro FM. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review. Gynecol Oncol. 2013;128(3):442–448. doi:10.1016/j.ygyno.2012.11.017
   PubMed Web of Science ®Google Scholar
• Eduardo MGDP, Campaner AB, Silva MALG. Apoptosis phenomena in squamous cell carcinomas and adenocarcinomas of the uterine cervix. Pathol Oncol Res. 2015;21(4):887–892. doi:10.1007/s12253-015-9906-y
   PubMed Web of Science ®Google Scholar
• Liu B, Xu Y, Hu B, et al. Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma. Aging. 2024;16(1):568–592. doi:10.18632/aging.205397
   PubMedGoogle Scholar
• Yang S, Wu Y, Deng Y, et al. Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors. Oncoimmunology. 2019;8(12):e1659094. doi:10.1080/2162402X.2019.1659094
   PubMed Web of Science ®Google Scholar
• Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models. Cancer Epidemiol. 2009;18(3):792–800. doi:10.1158/1055-9965.EPI-08-0965
   Web of Science ®Google Scholar
• Hu K, Wang W, Liu X, Meng Q, Zhang F. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy. Radiat Oncol. 2018;13(1). doi:10.1186/s13014-018-1197-5
   Google Scholar
• Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced‐stage, but not early‐stage, cervical carcinoma. Cancer-Am Cancer Soc. 2003;97(9):2196–2202. doi:10.1002/cncr.11371
   Google Scholar
• Xie X, Song K, Cui B, Jiang J, Yang X, Kong B. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB–IIA cervical cancer. Int J Clin Oncol. 2018;23(3):522–531. doi:10.1007/s10147-017-1225-8
   PubMed Web of Science ®Google Scholar
• Meng Y, Chu T, Lin S, et al. Clinicopathological characteristics and prognosis of cervical cancer with different histological types: a population-based cohort study. Gynecol Oncol. 2021;163(3):545–551. doi:10.1016/j.ygyno.2021.10.007
   PubMed Web of Science ®Google Scholar
• Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28. doi:10.1038/s41392-020-0134-x
   PubMed Web of Science ®Google Scholar